A large proportion of ameloblastomas harbor BRAF(V600E) mutation, the BRAF inhibitor with or without the combination of MEK inhibitor was applied in several cases of unresectable or recurrent ameloblastoma harboring BRAF(V600E) mutation [44,45,46,47]. Here, BRAF is linked to ameloblastoma.